If there is a public health benefit to the emergence of e-cigarettes, it will only come if they are effective at helping smokers end the use of cigarettes and if they are marketed in a way that prevents the re-glamorization of smoking among young people.
These goals can be achieved only through effective oversight by the Food and Drug Administration, not by circumventing it.
